logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (ii) New outpatient clients, primary drug distribution by age (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opioids1.57.825.134.038.841.445.042.141279381
Cocaine1.36.217.726.930.731.327.724.5301611830
Stimulants2.34.86.35.34.74.13.73.1674047
Hypnotics and sedatives0.60.91.31.41.82.33.49.9302994
Hallucinogens0.50.70.80.60.30.20.20.26900
Volatile substances5.20.70.10.10.10.10.20.14485
Cannabis 87.277.747.831.022.719.217.915.154418965
Other substances 1.41.20.80.80.91.41.95.018684
Total261624742288132638420704151461026099681386333326
 

Notes:

All countries included excluding Lithuania.

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-102 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI outpatient and inpatient treatment centres.

Page last updated: Monday, 09 July 2012